Premier Biomedical, Inc.
BIEI
$0.0004
-$0.0002-33.33%
| 12/31/2019 | 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Net Income | 81.11% | 20.00% | -431.39% | 113.65% | -38.02% |
| Total Depreciation and Amortization | -12.50% | 14.29% | 16.67% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | 503.94% | 220.00% | 365.52% | -95.18% | -65.95% |
| Total Other Non-Cash Items | -695.42% | -47.28% | 173.26% | -144.35% | 265.47% |
| Change in Net Operating Assets | 401.84% | -114.85% | -154.89% | 143.60% | -9.61% |
| Cash from Operations | 27.70% | 8.31% | -57.96% | 46.36% | 0.55% |
| Capital Expenditure | -- | 100.00% | 25.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 25.00% | -- | -- |
| Total Debt Issued | -80.53% | 11.65% | 76.92% | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -80.53% | 11.65% | 76.92% | -56.67% | -16.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -252.32% | 420.69% | 203.57% | -123.73% | -55.39% |
